Nostrum Loses Asthma Drug FDA Fight At DC Circ.
By Adam Lidgett ( June 3, 2022, 8:41 PM EDT) -- The District of Columbia Circuit Court has shot down an appeal in Nostrum Pharmaceuticals LLC's fight with the U.S. Food and Drug Administration on how it could produce a would-be generic form of a respiratory drug but did so only on jurisdictional grounds....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.